A detailed history of Front Row Advisors LLC transactions in Alcon Inc stock. As of the latest transaction made, Front Row Advisors LLC holds 40 shares of ALC stock, worth $3,805. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40
Previous 40 -0.0%
Holding current value
$3,805
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$74.84 - $88.15 $2,993 - $3,526
40 New
40 $3,000
Q1 2023

May 22, 2023

BUY
$64.46 - $77.23 $2,385 - $2,857
37 Added 1233.33%
40 $3,000
Q1 2023

May 15, 2023

SELL
$64.46 - $77.23 $2,385 - $2,857
-37 Reduced 92.5%
3 $4,000
Q3 2019

Nov 08, 2019

SELL
$58.2 - $62.42 $1,862 - $1,997
-32 Reduced 44.44%
40 $2,000
Q2 2019

Aug 27, 2019

BUY
$54.43 - $63.33 $3,918 - $4,559
72 New
72 $4,000

Others Institutions Holding ALC

About ALCON INC


  • Ticker ALC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 490,087,008
  • Market Cap $46.6B
  • Description
  • Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...
More about ALC
Track This Portfolio

Track Front Row Advisors LLC Portfolio

Follow Front Row Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.